Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles.

Tang S, Moayeri M, Chen Z, Harma H, Zhao J, Hu H, Purcell RH, Leppla SH, Hewlett IK.

Clin Vaccine Immunol. 2009 Mar;16(3):408-13. doi: 10.1128/CVI.00412-08. Epub 2009 Jan 7.

2.

Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.

Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Snawder JE, Robertson SA, Quinn CP.

Clin Vaccine Immunol. 2006 May;13(5):541-6.

3.

A novel homogeneous immunoassay for anthrax detection based on the AlphaLISA method: detection of B. anthracis spores and protective antigen (PA) in complex samples.

Mechaly A, Cohen N, Weiss S, Zahavy E.

Anal Bioanal Chem. 2013 May;405(12):3965-72. doi: 10.1007/s00216-013-6752-1. Epub 2013 Feb 7.

PMID:
23388689
4.

Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.

Stoddard RA, Quinn CP, Schiffer JM, Boyer AE, Goldstein J, Bagarozzi DA, Soroka SD, Dauphin LA, Hoffmaster AR.

J Immunol Methods. 2014 Jun;408:78-88. doi: 10.1016/j.jim.2014.05.008. Epub 2014 May 22.

5.

Femtomolar detection of the anthrax edema factor in human and animal plasma.

Duriez E, Goossens PL, Becher F, Ezan E.

Anal Chem. 2009 Jul 15;81(14):5935-41. doi: 10.1021/ac900827s.

PMID:
19522516
6.

Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen.

Tang S, Hewlett I.

J Infect Dis. 2010 Apr 15;201 Suppl 1:S59-64. doi: 10.1086/650386.

7.

Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

Welkos SL, Friedlander AM.

Microb Pathog. 1988 Jan;4(1):53-69.

PMID:
3143893
8.

Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology.

Soukka T, Antonen K, Härmä H, Pelkkikangas AM, Huhtinen P, Lövgren T.

Clin Chim Acta. 2003 Feb;328(1-2):45-58.

PMID:
12559598
9.

High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures.

Boyer AE, Gallegos-Candela M, Quinn CP, Woolfitt AR, Brumlow JO, Isbell K, Hoffmaster AR, Lins RC, Barr JR.

Anal Bioanal Chem. 2015 Apr;407(10):2847-58. doi: 10.1007/s00216-015-8509-5. Epub 2015 Feb 12.

10.

Generation and characterization of monoclonal antibodies to protective antigen of Bacillus anthracis.

Sastry KS, Tuteja U, Batra HV.

Indian J Exp Biol. 2003 Feb;41(2):123-8.

PMID:
15255603
11.

An immuno-diffusion assay to assess the protective antigen content of anthrax vaccine.

Adams T, Osborn S, Rijpkema S.

Vaccine. 2005 Aug 22;23(36):4517-20.

PMID:
15908061
12.

Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.

Harrison LH, Ezzell JW, Abshire TG, Kidd S, Kaufmann AF.

J Infect Dis. 1989 Oct;160(4):706-10.

PMID:
2507648
13.

Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.

Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Semenova V, Steward-Clark E, Stamey K, Freeman AE, Quinn CP, Snawder JE.

Clin Diagn Lab Immunol. 2004 Jan;11(1):50-5.

14.

Lateral flow immunoassay using europium chelate-loaded silica nanoparticles as labels.

Xia X, Xu Y, Zhao X, Li Q.

Clin Chem. 2009 Jan;55(1):179-82. doi: 10.1373/clinchem.2008.114561. Epub 2008 Oct 30.

15.

Rapid homogenous time-resolved fluorescence (HTRF) immunoassay for anthrax detection.

Cohen N, Mechaly A, Mazor O, Fisher M, Zahavy E.

J Fluoresc. 2014 May;24(3):795-801. doi: 10.1007/s10895-014-1354-7. Epub 2014 Feb 12.

PMID:
24515915
16.

Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand.

Sirisanthana T, Nelson KE, Ezzell JW, Abshire TG.

Am J Trop Med Hyg. 1988 Dec;39(6):575-81.

PMID:
3144920
17.

Detection of protective antigen, an anthrax specific toxin in human serum by using surface plasmon resonance.

Ghosh N, Gupta N, Gupta G, Boopathi M, Pal V, Goel AK.

Diagn Microbiol Infect Dis. 2013 Sep;77(1):14-9. doi: 10.1016/j.diagmicrobio.2013.05.006. Epub 2013 Jun 15.

PMID:
23773677
18.

Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.

Grunow R, Porsch-Ozcürümez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, Böhm R, Huber M, vd Esche U, Bessler W, Frangoulidis D, Finke EJ.

Vaccine. 2007 May 4;25(18):3679-83. Epub 2007 Jan 23.

PMID:
17287051
19.

Anthrax biosensor, protective antigen ion channel asymmetric blockade.

Halverson KM, Panchal RG, Nguyen TL, Gussio R, Little SF, Misakian M, Bavari S, Kasianowicz JJ.

J Biol Chem. 2005 Oct 7;280(40):34056-62. Epub 2005 Aug 8.

20.

Detection of anthrax toxin genetic sequences by the solid phase oligo-probes.

Addanki KC, Sheraz M, Knight K, Williams K, Pace DG, Bagasra O.

Indian J Med Microbiol. 2011 Oct-Dec;29(4):372-8. doi: 10.4103/0255-0857.90169.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk